Posted on May 01, 2016

The newly formed Qatar Metabolic Institute (QMI) will foster collaboration on clinical, education and research efforts amongst the country’s leading organizations, targeting metabolic diseases such as diabetes and obesity-related illnesses, according to H.E. Dr. Hanan Mohamed Al Kuwari (pictured), the Minister of Public Health.

Commenting on the inauguration of the QMI at its first conference which was held on Saturday, Her Excellency said: “The Qatar Metabolic Institute will become a central focal point for the country’s scientific research and medical enquiry relating to metabolic diseases, with the ultimate goal of providing population-specific improvements in health and disease outcomes, and initially targeting two of the greatest threats to health and wellbeing in Qatar – diabetes and obesity related illnesses, including stroke and cardiovascular disease.” “The combined resources within the country’s Academic Health System (AHS) partnership, as well as within other research institutions can utilize the QMI platform to promote collaboration on education and research programs, share knowledge, and aid in the understanding and prevention of metabolic diseases in Qatar,” H.E. Al Kuwari added.

Chair of the QMI and Chairman of the Department of Medicine at Hamad Medical Corporation (HMC), Professor Abdul-Badi Abou-Samra, highlighted that the institute plans to make the QMI conference an annual event. He said: “This year’s inaugural QMI conference welcomed a number of local and international speakers who provided valuable insights into their respective diabetes, cardiovascular disease and stroke studies, setting the stage for a dialogue between the various organizations within Qatar’s academic health system that will foster future collaborative research efforts.”

To facilitate these collaborations, the QMI has established centers of excellence to specifically address diabetes and obesity, added Prof. Abou-SamraThe QMI International Advisory Board is expected to meet this week to outline a strategy and define a pathway forward for collaboration on research programs and initiatives, Prof Abou-Samra concluded. The AHS partners include: HMC; Primary Health Care Corporation; Sidra Medical and Research Center; Qatar Biomedical Research Institute; Qatar University; Weill Cornell Medicine – Qatar; College of the North Atlantic – Qatar; and University of Calgary – Qatar. The partnership is managed from the AHS program offices in Hamad bin Khalifa Medical City, where the QMI is also located.